If investors want to understand the potential upside of our Neurotech development strain look at the $800m m/c company Neurotech,- Neuren.
Time will tell.
I think we are just cheap, but we in a very unforgiving sector, where investors are predominantly focused on resources and specifically the critical minerals, but that will change as it always does, just don't know when.
